These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 23843639)

  • 1. Hsp90 inhibitor 17-DMAG decreases expression of conserved herpesvirus protein kinases and reduces virus production in Epstein-Barr virus-infected cells.
    Sun X; Bristol JA; Iwahori S; Hagemeier SR; Meng Q; Barlow EA; Fingeroth JD; Tarakanova VL; Kalejta RF; Kenney SC
    J Virol; 2013 Sep; 87(18):10126-38. PubMed ID: 23843639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Epstein-Barr virus (EBV)-encoded protein kinase, EBV-PK, but not the thymidine kinase (EBV-TK), is required for ganciclovir and acyclovir inhibition of lytic viral production.
    Meng Q; Hagemeier SR; Fingeroth JD; Gershburg E; Pagano JS; Kenney SC
    J Virol; 2010 May; 84(9):4534-42. PubMed ID: 20181711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Destabilization of PDK1 by Hsp90 inactivation suppresses hepatitis C virus replication through inhibition of PRK2-mediated viral RNA polymerase phosphorylation.
    Kim MG; Moon JS; Kim EJ; Lee SH; Oh JW
    Biochem Biophys Res Commun; 2012 Apr; 421(1):112-8. PubMed ID: 22490666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Mechanism-Based Targeted Screen To Identify Epstein-Barr Virus-Directed Antiviral Agents.
    Li X; Akinyemi IA; You JK; Rezaei MA; Li C; McIntosh MT; Del Poeta M; Bhaduri-McIntosh S
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32796077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Niclosamide inhibits lytic replication of Epstein-Barr virus by disrupting mTOR activation.
    Huang L; Yang M; Yuan Y; Li X; Kuang E
    Antiviral Res; 2017 Feb; 138():68-78. PubMed ID: 27939840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Hsp90 inhibitor 17-DMAG decreases infection of porcine circovirus type 2 in mice.
    Liu J; You J; Zhang X; Ma C; Dong M; Chen L; Jiang P; Yun S
    Microb Pathog; 2017 Aug; 109():248-252. PubMed ID: 28602838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular chaperone Hsp90 is a therapeutic target for noroviruses.
    Vashist S; Urena L; Gonzalez-Hernandez MB; Choi J; de Rougemont A; Rocha-Pereira J; Neyts J; Hwang S; Wobus CE; Goodfellow I
    J Virol; 2015 Jun; 89(12):6352-63. PubMed ID: 25855731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sumoylation of the Epstein-Barr virus BZLF1 protein inhibits its transcriptional activity and is regulated by the virus-encoded protein kinase.
    Hagemeier SR; Dickerson SJ; Meng Q; Yu X; Mertz JE; Kenney SC
    J Virol; 2010 May; 84(9):4383-94. PubMed ID: 20181712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of mTORC1 inhibits lytic replication of Epstein-Barr virus in a cell-type specific manner.
    Adamson AL; Le BT; Siedenburg BD
    Virol J; 2014 Jun; 11():110. PubMed ID: 24917448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of maribavir and selected indolocarbazoles on Epstein-Barr virus protein kinase BGLF4 and on viral lytic replication.
    Gershburg E; Hong K; Pagano JS
    Antimicrob Agents Chemother; 2004 May; 48(5):1900-3. PubMed ID: 15105156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 17-DMAG induces heat shock protein 90 functional impairment in human bladder cancer cells: knocking down the hallmark traits of malignancy.
    Karkoulis PK; Stravopodis DJ; Voutsinas GE
    Tumour Biol; 2016 May; 37(5):6861-73. PubMed ID: 26662567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced tumor cell radiosensitivity and abrogation of G2 and S phase arrest by the Hsp90 inhibitor 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin.
    Bull EE; Dote H; Brady KJ; Burgan WE; Carter DJ; Cerra MA; Oswald KA; Hollingshead MG; Camphausen K; Tofilon PJ
    Clin Cancer Res; 2004 Dec; 10(23):8077-84. PubMed ID: 15585643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Schedule-dependent synergy between the heat shock protein 90 inhibitor 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin and doxorubicin restores apoptosis to p53-mutant lymphoma cell lines.
    Robles AI; Wright MH; Gandhi B; Feis SS; Hanigan CL; Wiestner A; Varticovski L
    Clin Cancer Res; 2006 Nov; 12(21):6547-56. PubMed ID: 17085670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr Virus BKRF4 Gene Product Is Required for Efficient Progeny Production.
    Masud HMAA; Watanabe T; Yoshida M; Sato Y; Goshima F; Kimura H; Murata T
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28904200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral activity of topoisomerase II catalytic inhibitors against Epstein-Barr virus.
    Wu T; Wang Y; Yuan Y
    Antiviral Res; 2014 Jul; 107():95-101. PubMed ID: 24821256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hsp90 inhibitors block outgrowth of EBV-infected malignant cells in vitro and in vivo through an EBNA1-dependent mechanism.
    Sun X; Barlow EA; Ma S; Hagemeier SR; Duellman SJ; Burgess RR; Tellam J; Khanna R; Kenney SC
    Proc Natl Acad Sci U S A; 2010 Feb; 107(7):3146-51. PubMed ID: 20133771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The heat-shock protein 90 inhibitor, geldanamycin, induces apoptotic cell death in Epstein-Barr virus-positive NK/T-cell lymphoma by Akt down-regulation.
    Jeon YK; Park CH; Kim KY; Li YC; Kim J; Kim YA; Paik JH; Park BK; Kim CW; Kim YN
    J Pathol; 2007 Oct; 213(2):170-9. PubMed ID: 17768706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heat shock protein 90 inhibitors: new mode of therapy to overcome endocrine resistance.
    Wong C; Chen S
    Cancer Res; 2009 Nov; 69(22):8670-7. PubMed ID: 19861537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HSP90 inhibitor, DMAG, synergizes with radiation of lung cancer cells by interfering with base excision and ATM-mediated DNA repair.
    Koll TT; Feis SS; Wright MH; Teniola MM; Richardson MM; Robles AI; Bradsher J; Capala J; Varticovski L
    Mol Cancer Ther; 2008 Jul; 7(7):1985-92. PubMed ID: 18645008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hsp90 inhibitors: a potential treatment for latent EBV infection?
    Sun X; Kenney SC
    Cell Cycle; 2010 May; 9(9):1665-6. PubMed ID: 20404505
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.